Deciphera Pharmaceuticals
Präsenz
Deciphera Pharmaceuticals ist einer der ...
Deciphera Pharmaceuticals ist ein Unternehmen, das unter dem Börsenticker DCPH (US) gelistet ist.
Führungskräfte
Siehe das Organigramm mit seine 23 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei Deciphera Pharmaceuticals
- Steven Hoerter, Director, President and Chief Executive Officer
- John Martin, Director
- James Bristol, Chairman of the Board
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Deciphera Pharmaceuticals nachzuverfolgen.
Pharmazie
Deciphera Pharmaceuticals hat 1.860 Konkurrenten , einschließlich Pfizer (USA), Sanofi (Frankreich) und Johnson & Johnson (USA).
Popular M&A news in Pharmazie
- MedMen has filed for bankruptcy protection (veröffentlicht am 28, April 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (veröffentlicht am 23, März 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (veröffentlicht am 19, März 2024).
Andere vorgeschlagene Kontakte der Pharmazie branche
Nachrichten
Neueste Pressemitteilungen nach Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- View more press releases Close
Social media about Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals auf Wikipedia, Google News & Yahoo Finance
- Deciphera Pharmaceuticals auf LinkedIn, Twitter & YouTube
In Kontakt kommen
Jetzt seine Führungskräfte, darunter auch Steven Hoerter, per E-Mail kontaktieren. 
Deciphera Pharmaceuticals unter +1 785... anrufen
